Adding a diabetes drug to improve blood sugar control
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if adding an SGLT2 inhibitor or a TZD medication to your current DPP4 inhibitor treatment can better manage your type 2 diabetes. It may be an option if your blood sugar levels are still too high.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have type 2 diabetes and your HbA1c is between 7.5% and 11.0%.
- You have been taking a DPP4 inhibitor, possibly with metformin or sulfonylurea, for at least 8 weeks without changing the dose.
- You have not taken an SGLT2 inhibitor or TZD in the last 8 weeks.
- You are not taking four or more diabetes medications currently.
- You do not have serious heart, kidney, or liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
This study compares two medications, trelagliptin and sitagliptin, to see which works better for people with type 2 diabetes. It might be an option if you are already taking metformin but your blood sugar levels are still not under control.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This study is testing two different diabetes pills—dapagliflozin or pioglitazone—in people with type 2 diabetes. The goal is to see which one works better when added to your current metformin and DPP-4 inhibitor. You may qualify if your blood sugar is not well controlled with your current medications.
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
This trial tests if adding pioglitazone to an SGLT2 inhibitor can lower blood sugar more and prevent high ketone levels in people with type 1 diabetes. It may help those who have poor blood sugar control despite insulin therapy.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.